|
JP3866809B2
(ja)
*
|
1996-12-19 |
2007-01-10 |
松下電器産業株式会社 |
有機膜及びその製造方法
|
|
US7250534B1
(en)
|
1999-07-27 |
2007-07-31 |
University Of South Florida |
Performance of energy storage devices: potential areas for dendritic chemistry involvement
|
|
US7448258B2
(en)
*
|
1999-10-29 |
2008-11-11 |
Avery Dennison Corporation |
High throughput screening for moisture barrier characteristics of materials
|
|
CA2425779C
(en)
|
2000-10-12 |
2013-08-06 |
University Of Rochester |
Compositions that inhibit proliferation of cancer cells
|
|
US20020146684A1
(en)
*
|
2001-04-09 |
2002-10-10 |
Meldal Morten Peter |
One dimensional unichemo protection (UCP) in organic synthesis
|
|
DE10158149A1
(de)
*
|
2001-11-28 |
2003-06-18 |
Bayer Ag |
Silangruppen enthaltende Polymere
|
|
CA2475112A1
(en)
|
2002-02-06 |
2003-08-14 |
Vicor Technologies, Inc. |
Anti-infarction molecules
|
|
AU2003253580A1
(en)
*
|
2002-02-26 |
2003-11-17 |
University Of Minnesota |
Variants of nedd4l associated with hypertension and viral budding
|
|
EP1575992A4
(en)
|
2002-08-05 |
2007-02-21 |
Univ Rochester |
CHEMICAL PROTEINS FROM PROTEIN TRANSDUCATING DOMAIN / DEAMINASE, RELATED COMPOUNDS AND THEIR USES
|
|
US20050106068A1
(en)
*
|
2003-11-18 |
2005-05-19 |
Abdul Malik |
Sol-gel dendron separation and extraction capillary column
|
|
CN101500481B
(zh)
|
2005-04-05 |
2014-07-02 |
康宁股份有限公司 |
一种测定刺激事件对细胞产生的影响的方法
|
|
ES2431315T3
(es)
|
2005-05-19 |
2013-11-26 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Epítopos funcionales del antígeno PsaA de Streptococcus pneumoniae y usos de los mismos
|
|
CA2625891A1
(en)
|
2005-10-14 |
2007-04-26 |
Carlton D. Donald |
Inhibition of pax2 by defb1 induction as a therapy for cancer
|
|
US8080534B2
(en)
|
2005-10-14 |
2011-12-20 |
Phigenix, Inc |
Targeting PAX2 for the treatment of breast cancer
|
|
WO2007048190A1
(en)
*
|
2005-10-25 |
2007-05-03 |
Starpharma Pty Limited |
Macromolecular compounds having controlled stoichiometry
|
|
EP3034083B1
(en)
|
2006-09-21 |
2020-12-09 |
University of Rochester |
Antisense oligonucleotides for use in treating myotonic dystrophy
|
|
US8999317B2
(en)
|
2006-11-01 |
2015-04-07 |
University Of Rochester |
Methods and compositions related to the structure and function of APOBEC3G
|
|
EP2117576B1
(en)
|
2007-02-08 |
2014-04-16 |
University Of Utah Research Foundation |
Methods and compositions related to inhibition of viral entry
|
|
AU2009281732A1
(en)
*
|
2008-08-15 |
2010-02-18 |
Georgetown University |
Na channels, disease, and related assays and compositions
|
|
EP2370080A1
(en)
|
2008-12-02 |
2011-10-05 |
University of Utah Research Foundation |
Pde1 as a target therapeutic in heart disease
|
|
WO2011022502A1
(en)
|
2009-08-18 |
2011-02-24 |
Georgetown University |
Boronic acid compositions and methods related to cancer
|
|
US20110081293A1
(en)
|
2009-10-07 |
2011-04-07 |
Sanford-Burnham Medical Research Institute |
Methods and compositions related to clot-binding lipid compounds
|
|
CA2784145A1
(en)
|
2009-12-18 |
2011-06-23 |
Sanford-Burnham Medical Research Institute |
Methods and compositions related to clot-binding compounds
|
|
EP2691105B1
(en)
|
2011-03-28 |
2018-07-11 |
University of Utah Research Foundation |
Methods and compositions related to inhibition of viral entry
|
|
US12025615B2
(en)
|
2017-09-15 |
2024-07-02 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Methods of classifying response to immunotherapy for cancer
|
|
WO2021067550A1
(en)
|
2019-10-02 |
2021-04-08 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Methods and compositions for identifying neoantigens for use in treating and preventing cancer
|